跳至主要内容
临床试验/NCT03031717
NCT03031717Unknown不适用

Follow-up and Survival of Cirrhotic and Non Cirrhotic Patients With Portal Vein Thrombosis Treated With Transjugular Intrahepatic Portosystemic Shunt

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
15
试验地点
1
主要终点
Outcome of TIPS for PVT in patients with and without cirrhosis

研究概览

简要总结

Portal vein thrombosis (PVT) is defined as an obstruction of the portal vein. The prevalence of PVT is 10-25% and incidence is about 16% in cirrhotic patients. PVT leads to increased intrahepatic resistance, decreased portal velocities, splanchnic vasodilatation, and stagnant flow.

Portal vein recanalization (PVR) with transjugular intrahepatic portosystemic shunt (TIPS) is aimed at restoring main portal vein (PV) flow in chronic PVT. In this study, we will review the safety and outcomes of this approach.

详细描述

Portal vein thrombosis (PVT) is a fairly common complication of liver cirrhosis. Importantly, occlusive PVT might influence the prognosis of patients with cirrhosis. Transjugular intrahepatic portosystemic shunt (TIPS) has been reported to be an effective treatment of PVT in cirrhosis, with the advantage of avoiding the risk of bleeding linked to anticoagulation. In this study, we will evaluate the outcome of TIPS for PVT in patients with and without cirrhosis and determinate survival.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent
  • Liver cirrosis or non-cirrhotic patients
  • Portal vein thrombosis (degree of vessel obstruction > 50%)

排除标准

  • Active variceal bleeding
  • Prior history of TIPS placement or shunt surgery
  • Concomitant renal insufficiency
  • Severe cardiopulmonary diseases
  • Uncontrolled sepsis Serious medical conditions which may reduce the life expectancy
  • Contraindications for TIPS

结局指标

主要结局

Outcome of TIPS for PVT in patients with and without cirrhosis

时间窗: 5 years

Clinical evolution after placement of TIPS

次要结局

未报告次要终点

研究者

发起方
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
申办方类型
Other
责任方
Principal Investigator
主要研究者

ALDO TORRE DELGADILLO

MD

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

研究点 (1)

Loading locations...

相似试验